Clinical trial
A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition
NCT00287066 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00287066 |
|---|---|
| Title | A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition |
| Official title | Open-Label Randomized Two-Way Crossover Pilot Study To Estimate The Effects Of Inhaled Versus IV Infusion Of Human Insulin With Regards To Glucose Disposal In Subjects With Type 1 Diabetes Mellitus |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Inhaled Human Insulin, Regular Human Insulin |
| Enrollment | 22 |
| Start date | Feb 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Feb 6, 2006 |
| Last update posted | Feb 21, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: